The Kidney as an Endocrine Organ

Chayen J Daley JR Loveridge N Bitensky L. The cytochemical bioassay of hormones. Recent Progr Hormone Res 1976; 32: 33–79.

de Wardener HE MacGregor GA Clarkson EM Alaghband-Zadeh J Bitensky L Chayen J. Effect of sodium intake on ability of human plasma to inhibit renal Na⁺–K⁺–adenosine triphophatase in vitro . Lancet 1981; 1: 411–412.

Dikstein S. Stimulability, adenosine triphosphatases and their control by cellular redox processes. Naturwissenschafter 1971; 58: 439–443.

Fenton S Clarkson EM MacGregor GA Alaghband-Zadeh J de Wardener HE . An assay of the capacity of biological fluids to stimulate renal glucose-6-phosphate dehydrogenase (G6PD) activity in vitro as a marker of their ability to inhibit sodium-potassium dependent adenosine triphosphatase (Na⁺–K⁺–ATPase) activity. J Endocrinol 1982; 94: 99–110.

de Wardener HE . Natriuretic hormone. Clin Sci Mol Med 1977; 535: 1–8.

de Wardener HE Clarkson EM . The natriuretic hormone: Recent developments. Clin Sci 1982; 63: 415–420.

Clarkson EM Koutsaimanis KG Davidman M DuBois M Penn WP de Wardener HE . The effect of brain extracts on urinary sodium excretion of the rat and the intracellular sodium concentration of renal tubule fragments. Clin Sci Mol Med 1974; 47: 201–213.

Alaghband-Zadeh J Fenton S Hancock K Millett J de Wardener HE . Evidence that the hypothalamus may be a source of a circulating Na⁺–K⁺–ATPase inhibitor. J Endocrinol 1983; 98: 221–226.

Epstein M. Cardiovascular and renal effects of head-out water immersion in man. Application of the model in the assessment of volume homeostasis. Circ Res 1976; 39: 619–628.

Epstein M Bricker NS Bourgoignie JJ . Presence of a natriuretic factor in urine of normal men undergoing water immersion. Kidney Int 1978; 13: 152–158.

Dahl LK Heine M. Primary role of renal homografts in setting chronic blood pressure levels in rats. Circ Res 1975; 36: 692–696.

Bianchi G Fox U Di Francesco GF Giovanetti AM Pagetti D. Blood pressure changes produced by kidney cross transplantation between spontaneously hypertensive rats and normotensive rats. Clin Sci Mol Med 1974; 47: 435–438.

Kawabe K Watanebe TX Shiono K Sokabe H. Influence of blood pressure on renal isografts between spontaneously hypertensive and normotensive rats utilizing the F₁ Hybrids. Japan Heart J 1979; 20: 886–894.

Poston L Sewell RB Wilkinson SP . Evidence for a circulating sodium transport inhibitor in essential hypertension. Br Med J 1981; 282: 847–849.

Edmondson RPS MacGregor GA . Leucocyte cation transport in essential hypertension; its relation to the renin-angiotensin system. Br Med J 1981; 282: 1267–1269.

MacGregor GA Fenton S Alaghband-Zadeh J Markandu ND Roulston JE de Wardener HE . Evidence for a raised concentration of a circulating sodium transport inhibitor in essential hypertension. Br Med J 1981; 283: 1355–1357.

Hamlyn JM Ringel R Shaeffer J . A circulating inhibitor of (Na⁺–K⁺–)ATPase associated with essential hypertension. Nature 1982; 100: 650–652.

Blaustein MP . Sodium ions, calcium ions, blood pressure regulation and hypertension: A reassessment and hypothesis. Am J Physiol 1977; 232 (3): C165–C173.

Ellis CN Julius S. Role of central blood volume in hyperkinetic borderline hypertension. Br Med J 1973; 35: 450–455.

Haraldsson B Nilsson H Folkow B. Structurally reduced distensibility of cardiovascular ‘low-pressure’ compartments in primary hypertension as studied in spontaneously hypertensive rats (SHR). Acta Physiologica Scand 1981; 112: 473–480.

London GM Safar ME Simon AC Alexander JM Levenson JA Weiss YA . Total effect compliance, cardiac output and fluid volumes in essential hypertension. Circulation 1978; 57: 995–1000.

Esler M Julius S Randell O. Relationship of volume factors, renin and neurogenic vascular resistance in borderline hypertension. In Rosive G van Caulvenbarge H. eds. The arterial hypertensive disease. New York: Masson Inc. 1976: 231

de Wardener HE MacGregor GA . The relation of a circulating sodium transport inhibitor (The natriuretic hormone) to hypertension. Medicine 1983;

Skeggs LT Lentz KE Hochstrasser H Kahn Jr Kinetics of the reaction of renin with nine synthetic peptide substrates. J Exper Med 1968; 128: 13–34.

Kokubu T Ueda E Fujimoto S .Nature 1968; 217: 456.

Poulsen K Burton J Haber E. Competitive inhibitors of renin. Biochemistry 1973; 12: 3877–3882.

Cody RJ Burton J Evin G Poulsen K Herd JA Haber E. Biochem Biophys Res Comm 1980; 97: 230–235.

Parry MJ Russell AB Szelke M. Bio-isosteres of a peptide renin inhibitor. In Meienhofer J. ed. Chemistry and Biology of Peptides. Ann Arbor Science Publishers. 1972; 541.

Szelke M Leckie BJ Tree M . H-77, a potent new renin inhibitor. In vitro and in vivo studies. Hypertension 1982; 4: 59–69.

Szelke M Leckie B Hallet A . Potent new inhibitors of human renin. Nature 1982; 299: 555–557.

Millar JA Leckie BJ Morton JJ Jordan J Tree M. A micro assay for active and total renin concentration in human plasma based on antibody trapping. Clin Clim Acta 1980; 101: 5–15.

Morton JJ Semple PF Waite MA Brown JJ Lever AF Robertson JIS . In Ed. Antoniades HN , Hormones in human blood. Cambridge Massachusetts: Harvard University Press 1976; 607.

Boger J Lohr NS Ulm EH . Novel renin inhibitors containing the amino acid statine. Nature years 303: 8184.

Szelke M Jones DM Atrash B Hallett A Leckie B. Novel transition-state analogue inhibitors of renin. Peptides 1983; (in press)

Hell RC Brogden RN Speight TM Avery GS . Captopril: A preliminary review of its pharmacological properties and therapeutic efficiency. Drugs 1980; 20: 409–452.

Hodsman GP Robertson JIS . Captopril: Five years on. Br Med J 1983; 287: 851–852.

Hodsman GP Brown JJ Cumming AMM . Enalapril (MK421) in the treatment of hypertension with renal artery stenosis. J Hypertension 1983;(suppl I)109–117.

Maslowski AH Nicholls MG Ikram H Espiner EA . Haemodynamic hormonal and electrolyte response to captopril in resistant heart failure. Lancet 1981; 1: 71–74.

Brown JJ Leckie BJ Lever AF . In ( Robertson JIS , ed.) Handbook of Hypertension Amsterdam Elsevier, 1983; 1: 278–323.

Schalekamp MADH Derkx FHM . Clin Sci 1981; 61: 15–21.

Sealey JE Atlas SA Laragh JH . Clin Sci 1982; 63: 113s–145s.

Poulsen K Vuust J Lund T. Clin Sci 1980; 59: 297–299.

Parmentier M Inagami T Pochet R. Clin Sci 1983; 65: 475–477.

Carlson W Quay S Dzau V Kreisberg J Slater E Haber E. In ( Sambhi MP , ed) Heterogeneity of Renin and Renin-Substrate Amsterdam: Elsevier 1981: 33–43.

McIntyre GD Leckie B Hallett A Szelke M. Biochem J 1983; 211: 519–522.

Leckie BJ , (1981) Clin Sci 1981; 60: 119–130.

Fouad FM Tarazi RC Bravo EL Hart NM Castle LW Salcedo EE . Long-term control of congestive heart failure with captopril. Am J Cardiol 1982; 49: 1489–1496.

Colucci WS Wynne J Holman BL Braunwald E. Long-term therapy of heart failure with prazosin: A randomized double-blind trial. Am J Cardiol 1980; 45: 337.

Tarazi RC Fouad FM Ceimo JK Bravo EL . Renin, aldosterone and cardiac decompensation: Studies with an oral converting enzyme inhibitor in heart failure. Am J Cardiol 1979; 1013–1018.

Franciosa JA Wilen M Ziesche S Cohn J. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1983; 51: 831–836.